Cardiac MRI: When We Order It, What It Shows, and What the Results Mean

A 38-year-old man with new heart failure of unclear cause walks into clinic. His echocardiogram shows reduced ejection fraction. His coronaries are normal on cardiac CT. His lab work doesn't point to a clear etiology. His next test is a cardiac MRI, and the results will likely shape the next decade of his care.

I'm Dr. Damian Rasch, a cardiologist in Encinitas. Cardiac MRI has become one of the most powerful tools in modern cardiology because it gives us tissue-level information that no other test provides. It can distinguish ischemic from non-ischemic cardiomyopathy. It can identify infiltrative diseases like amyloidosis or sarcoidosis. It can quantify scar burden, characterize myocarditis, and measure ejection fraction with greater precision than echo. This article walks through what cardiac MRI does, when it's the right test, what the various sequences show, and how to think about the results once they come back.

What Cardiac MRI Actually Does

A cardiac MRI uses powerful magnets and radio waves to produce detailed images of the heart's structure and tissue characteristics. The patient lies in a tube-shaped scanner, holds their breath at intervals, and the scanner captures images timed to the heartbeat. A typical study takes 45 to 60 minutes. There's no radiation. The most informative sequences usually require gadolinium contrast, which is given through an IV.

What makes cardiac MRI distinctive among heart tests is its ability to characterize tissue. An echocardiogram shows whether the heart is squeezing well; a cardiac MRI shows that and also tells us whether the muscle is normal, scarred, inflamed, fibrotic, or infiltrated with abnormal substances. The pattern of these tissue changes often points to a specific underlying disease, which is why cardiac MRI is so valuable in patients with unexplained cardiomyopathy or unusual clinical pictures.

The Main Sequences and What Each Shows

Cine Imaging

Cine sequences capture moving images of the heart in motion. They show the heart contracting and relaxing in real time across multiple imaging planes. From these movies, we measure ejection fraction (with greater accuracy than echo, especially in patients with poor echo windows), wall motion, chamber sizes, and valve function. Cine imaging is the foundational structural information.

Late Gadolinium Enhancement (LGE)

Late gadolinium enhancement is the most diagnostically valuable sequence. After IV gadolinium contrast is given, the contrast washes out of normal myocardium quickly but lingers in areas of scar or fibrosis. Imaging done 10 to 20 minutes after contrast injection shows these areas as bright spots against the dark normal myocardium. The pattern of LGE often points to a specific diagnosis.

Subendocardial LGE in a coronary distribution suggests prior myocardial infarction. Mid-wall LGE in the basal septum suggests sarcoidosis or some non-ischemic cardiomyopathies. Diffuse subendocardial LGE that doesn't follow a coronary distribution, often described as "ghost myocardium," suggests cardiac amyloidosis. Patchy mid-wall LGE in younger patients with chest pain suggests myocarditis. Subepicardial LGE in the lateral wall suggests certain inflammatory or genetic cardiomyopathies. The pattern reading is one of the more useful diagnostic exercises in cardiology.

T1 and T2 Mapping

T1 and T2 mapping are newer techniques that quantify the magnetic relaxation properties of tissue. T1 mapping (especially extracellular volume calculation after contrast) detects diffuse fibrosis that wouldn't show up as discrete LGE. T2 mapping detects edema, the fluid signal that marks active inflammation. These maps add precision to the diagnosis of myocarditis, amyloidosis, and other conditions where the tissue characterization needs to go beyond what LGE alone can show.

Native T1 (without contrast) is used to detect iron overload (low T1 in hemochromatosis) and amyloidosis (high T1). T2* (T2 star) is the dedicated sequence for iron overload assessment, with values below 20 ms indicating significant iron deposition.

Stress Imaging

Cardiac MRI can also be used as a functional stress test, with vasodilator stress (regadenoson or adenosine) producing a perfusion defect in regions supplied by significantly narrowed coronary arteries. Stress cardiac MRI has higher sensitivity than nuclear stress testing for ischemia and similar specificity, with no radiation exposure. Availability is limited, but where it's offered, stress cardiac MRI is an excellent option for ischemia evaluation.

When We Order Cardiac MRI

Unexplained Cardiomyopathy

Patients with reduced ejection fraction or thickened heart walls of unclear cause are the largest group sent for cardiac MRI. The differential includes ischemic cardiomyopathy from prior silent infarction, dilated cardiomyopathy of various etiologies, hypertrophic cardiomyopathy, restrictive cardiomyopathy, infiltrative diseases (amyloidosis, sarcoidosis, hemochromatosis), and inflammatory conditions (myocarditis). Cardiac MRI sorts through this differential more effectively than any other non-invasive test.

Suspected Myocarditis

Patients with chest pain, elevated troponin, EKG changes, and clean coronaries on angiography often have myocarditis as the diagnosis. Cardiac MRI can confirm the diagnosis with characteristic findings of edema (high T2 signal) and patchy mid-wall or subepicardial LGE in a non-coronary distribution. The Lake Louise criteria use a combination of these findings to make the diagnosis with high specificity. The COVID era brought a wave of cardiac MRI studies in patients with post-vaccine or post-infection myocarditis.

Suspected Amyloidosis

Patients with unexplained left ventricular hypertrophy, especially with low EKG voltage, biatrial enlargement, or restrictive physiology, deserve workup for cardiac amyloidosis. Cardiac MRI shows the characteristic diffuse subendocardial LGE pattern. T1 mapping shows elevated native T1 and elevated extracellular volume. These findings, combined with technetium pyrophosphate scanning and serologic workup for AL amyloidosis, make the diagnosis.

Suspected Cardiac Sarcoidosis

Patients with unexplained heart block, ventricular arrhythmias, or non-ischemic cardiomyopathy in younger or middle-aged adults deserve a workup for cardiac sarcoidosis. Cardiac MRI typically shows patchy mid-wall and subepicardial LGE, especially in the basal septum. Combined with FDG-PET for active inflammation, MRI helps establish the diagnosis and guide treatment.

Hypertrophic Cardiomyopathy

Cardiac MRI is the most accurate test for measuring wall thickness in hypertrophic cardiomyopathy and for identifying scar burden, which predicts arrhythmic risk. Patients with HCM often get serial MRIs to track disease progression and inform decisions about ICD placement.

Arrhythmogenic Cardiomyopathy

Patients with ventricular arrhythmias and family history of sudden death may have arrhythmogenic right ventricular cardiomyopathy or its variants. Cardiac MRI shows the characteristic right ventricular dilation, dysfunction, and fatty infiltration that supports the diagnosis.

Congenital Heart Disease

Adults with repaired congenital heart disease often need cardiac MRI for serial follow-up of right ventricular size and function (after tetralogy of Fallot repair, for example), pulmonary regurgitation severity, and overall hemodynamic assessment. MRI does this without radiation, which matters in young patients who will need imaging for decades.

Contraindications and Special Situations

Implanted Devices

Patients with pacemakers, ICDs, or other electronic implants used to be barred from MRI altogether. That's no longer true. MRI-conditional devices (which include the vast majority of devices implanted in the last 10 to 15 years) can be safely imaged in MRI scanners with appropriate device programming and monitoring. Older non-conditional devices may still be imaged in some centers with strict protocols. The decision is individualized and made in consultation with the patient's electrophysiologist.

Claustrophobia

The MRI tunnel is narrow, and some patients can't tolerate it. Wide-bore MRI scanners are larger and better tolerated. Mild sedation (oral lorazepam, for example) helps many patients. Open MRI scanners exist but typically have lower image quality. For patients with severe claustrophobia, sedation or alternative testing may be needed.

Renal Disease

Older gadolinium contrast agents carried a risk of nephrogenic systemic fibrosis (NSF) in patients with severe kidney disease. Newer macrocyclic gadolinium agents have a much lower risk and are considered safe in most patients with mild to moderate kidney disease. For patients on dialysis, the decision is individualized.

Atrial Fibrillation

Cardiac MRI uses cardiac gating to time images to the heartbeat. Atrial fibrillation, with its irregular rhythm, can degrade image quality. Modern scanners have improved gating algorithms that handle AFib better than older systems, but very irregular rhythms can still produce suboptimal images. Rate control before the scan can help.

Pregnancy

MRI without gadolinium is generally considered safe in pregnancy and is the preferred imaging modality in pregnant patients with cardiac concerns. Gadolinium contrast crosses the placenta and is generally avoided in pregnancy unless absolutely necessary.

Reading the Report

A cardiac MRI report typically describes left and right ventricular size and function (with quantitative measurements of ejection fraction, end-diastolic volume, and mass), wall thickness, valve function (regurgitation severity, stenosis if present), late gadolinium enhancement pattern, T1/T2 mapping values when performed, and any specific diagnostic conclusion (myocarditis, amyloidosis, sarcoidosis, etc.). The report should also flag any incidental findings (small pericardial effusion, mediastinal lymphadenopathy, lung findings).

The most diagnostically useful piece of the report is usually the LGE pattern. Subendocardial LGE in a coronary distribution means prior infarction, with implications for risk stratification and antiplatelet therapy. Mid-wall LGE in the basal septum in a younger patient suggests sarcoidosis. Diffuse subendocardial LGE suggests amyloidosis. Patchy mid-wall LGE in the lateral wall suggests myocarditis or certain genetic cardiomyopathies. The pattern, combined with the clinical picture, often makes the diagnosis.

What the Findings Mean for Treatment

Ischemic Pattern

If LGE shows a subendocardial coronary pattern, the patient has had infarction in that territory. The implications are aggressive secondary prevention with antiplatelet therapy, statin, blood pressure control, and consideration of additional ischemia evaluation if the patient has ongoing symptoms or hasn't been worked up.

Non-Ischemic Pattern

Mid-wall or subepicardial LGE without a coronary pattern points to a non-ischemic cardiomyopathy. The specific subtype (sarcoidosis, myocarditis, genetic cardiomyopathy, infiltrative disease) drives the management. Patients with significant LGE in non-ischemic cardiomyopathy are at higher risk for ventricular arrhythmias and may be candidates for ICD placement at lower thresholds than would otherwise apply.

No LGE

A patient with reduced ejection fraction but no LGE has a relatively favorable prognosis compared to similar patients with extensive LGE. The absence of fibrosis suggests reversible causes are more likely (tachycardia-mediated cardiomyopathy, recent myocarditis with healing, alcohol-related, peripartum cardiomyopathy) and the chance of recovery with optimal medical therapy is higher.

Specific Diagnoses

When MRI confirms amyloidosis, sarcoidosis, hemochromatosis, or another specific diagnosis, the treatment becomes disease-targeted: tafamidis or vutrisiran for ATTR amyloidosis, immunosuppression for sarcoidosis, phlebotomy for hemochromatosis. These targeted therapies often produce dramatically better outcomes than treating these conditions as generic non-ischemic cardiomyopathy.

Limitations of Cardiac MRI

Cardiac MRI isn't perfect. Image quality depends on the patient's ability to hold their breath, the regularity of their heart rhythm, and the scanner and technician quality. Significant arrhythmia, severe claustrophobia, or inability to lie flat can degrade or prevent the study. Some metal hardware (older devices, certain orthopedic implants) limits or contraindicates MRI. Cost is higher than echo or stress testing, and insurance prior authorization is sometimes required.

Interpretation requires expertise. Cardiac MRI reading is its own subspecialty, and not every center has dedicated cardiac MRI radiologists or cardiologists. The diagnostic value of the test depends heavily on the reader's dedicated cardiac MRI experience.

Common Patient Questions

Why didn't they just do an echo?

Echo and cardiac MRI answer different questions. Echo measures size, function, and valve performance. Cardiac MRI does that and adds tissue characterization. When the clinical question is "why does this heart have reduced function" or "is this hypertrophy from amyloidosis," echo can't answer it but cardiac MRI usually can. Echo is usually the first test; MRI is added when echo doesn't fully answer the clinical question.

Is the contrast dangerous?

Modern macrocyclic gadolinium agents have very low risk profiles for patients with normal or mildly reduced kidney function. The risk of nephrogenic systemic fibrosis with these agents is close to zero. Allergic reactions occur but are rare. Trace amounts of gadolinium can deposit in the brain, but no clinical consequences have been demonstrated. The risk-benefit calculation strongly favors the test in patients who genuinely need the diagnostic information.

How long does the scan take?

A complete cardiac MRI takes 45 to 60 minutes from when imaging starts. With check-in, IV placement, and post-scan recovery, plan on 90 minutes to 2 hours total. Bring something to listen to (most scanners can play music through earbuds) and dress comfortably.

I have claustrophobia. Can I still get this test?

Often, yes. Wide-bore scanners are large and well tolerated by most claustrophobic patients. Mild sedation (oral lorazepam taken before the appointment) helps many patients. Some centers have open MRI scanners, although these typically have lower image quality. If you have severe claustrophobia, talk to the imaging center ahead of time so they can plan accordingly.

Can I still get this test if I have a pacemaker?

Probably yes. Most pacemakers and ICDs implanted in the last decade are MRI-conditional, meaning they can be safely imaged in MRI scanners with appropriate device programming and monitoring. Your electrophysiologist will reprogram the device before the scan and after, and a device technician monitors during the scan. Older non-conditional devices can sometimes still be imaged in centers with experience, although safety considerations are different.

What if my MRI shows scar I didn't know I had?

Discovering unexpected scar on MRI is common, especially when the indication was something else. The implications depend on the pattern and size of the scar. A small subendocardial scar in a coronary distribution suggests a prior silent myocardial infarction and warrants secondary prevention. Mid-wall scar of unclear etiology may need additional workup to establish the underlying cause. The cardiologist who ordered the test will help you understand what the finding means.

Why is this test more expensive than other heart tests?

Cardiac MRI is more expensive because the equipment is expensive (a 1.5 or 3 Tesla scanner costs millions of dollars), the scan takes longer than most other imaging studies, and it requires specialized cardiac imaging expertise to perform and interpret. The diagnostic value justifies the cost when the clinical question requires the information that MRI uniquely provides.

When to Escalate Care

Call 911 immediately for severe chest pain, shortness of breath at rest, or syncope, regardless of pending or recent testing. The MRI doesn't change emergency-level symptoms, which need immediate evaluation.

Contact your cardiologist the same day for new heart failure symptoms (worsening shortness of breath, leg swelling, weight gain), new chest pain, palpitations with concerning features, or any concerns about results received from imaging.

Schedule a clinic visit within one to two weeks to review MRI results in detail with your cardiologist. The report read alone doesn't replace the conversation about what the findings mean for your care plan.

A Final Note From Me

Cardiac MRI has changed how I practice cardiology. Patients who used to be labeled "non-ischemic cardiomyopathy of unclear etiology" now often get a precise diagnosis. The treatment difference between generic non-ischemic cardiomyopathy and a specific diagnosis like amyloidosis or sarcoidosis is enormous, and getting the diagnosis right early in the course matters for long-term outcomes. If you have unexplained heart failure, unexplained ventricular arrhythmias, unexplained left ventricular hypertrophy, or any cardiac picture that doesn't fit cleanly into a standard diagnosis, ask whether cardiac MRI would help.

If you've had a cardiac MRI and you're trying to understand what the report means, the patterns of late gadolinium enhancement are the most diagnostically informative piece. Ask your cardiologist to walk through what the LGE pattern shows, what it suggests about the underlying disease, and what the management implications are. The report itself uses technical language that's hard to interpret without context, but the clinical picture usually becomes clear with explanation.

If you've been told you don't need a cardiac MRI but you're not sure why, ask. The test isn't appropriate for everyone, but the indications are broader than they used to be, and patients sometimes don't get referred when they would benefit. The patients I worry about are the ones whose unexplained findings on echo or stress testing never got the next-step MRI evaluation. The patients I'm hopeful about are the ones who got a clear MRI-driven diagnosis and are on disease-specific therapy.

References

1. Kramer, Christopher M., Juerg Barkhausen, Chiara Bucciarelli-Ducci, et al. "Standardized Cardiovascular Magnetic Resonance Imaging (CMR) Protocols: 2020 Update." Journal of Cardiovascular Magnetic Resonance 22, no. 1 (2020): 17.

2. Ferreira, Vanessa M., Sven Plein, Tim Wong, et al. "Cardiovascular Magnetic Resonance for Evaluation of Cardiac Involvement in COVID-19-Related Inflammatory and Non-Inflammatory Conditions." Journal of Cardiovascular Magnetic Resonance 25, no. 1 (2023): 21.

3. Friedrich, Matthias G., Udo Sechtem, Jeanette Schulz-Menger, et al. "Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper." Journal of the American College of Cardiology 53, no. 17 (2009): 1475-1487.

4. Fontana, Marianna, Stefania Rosmini, Daniel S. Knight, et al. "Native T1 Mapping in Cardiac Amyloidosis." JACC: Cardiovascular Imaging 7, no. 2 (2014): 157-165.

5. Greulich, Simon, Christof Sebastian Deluigi, Stefanie Gloekler, et al. "CMR Imaging Predicts Death and Other Adverse Events in Suspected Cardiac Sarcoidosis." JACC: Cardiovascular Imaging 6, no. 4 (2013): 501-511.

6. Maron, Martin S., Iacopo Olivotto, Charlene Harrigan, et al. "Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy." Circulation 124, no. 1 (2011): 40-47.

7. Greenwood, John P., Neil Maredia, John F. Younger, et al. "Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography for Diagnosis of Coronary Heart Disease (CE-MARC): A Prospective Trial." Lancet 379, no. 9814 (2012): 453-460.

8. Indorkar, Ratna, Robert Kwong, Susan Romano, et al. "Global Coronary Flow Reserve Measured during Stress Cardiac Magnetic Resonance Imaging Is an Independent Predictor of Adverse Cardiovascular Events." JACC: Cardiovascular Imaging 12, no. 8 (2019): 1686-1695.

9. Hundley, W. Gregory, David A. Bluemke, J. Paul Finn, et al. "ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance." Journal of the American College of Cardiology 55, no. 23 (2010): 2614-2662.

10. Doltra, Adelina, Sergio Hoyos Amador, Stephanie Wassmuth, et al. "Emerging Concepts for Myocardial Late Gadolinium Enhancement MRI." Current Cardiology Reviews 9, no. 3 (2013): 185-190.

Published on damianrasch.com. The above information was composed by Dr. Damian Rasch, drawing on individual insight and bolstered by digital research and writing assistance. The information is for educational purposes only and does not constitute medical advice.